16 results on '"Taplin, Stephen H."'
Search Results
2. Effect of Previous Benign Breast Biopsy on the Interpretive Performance of Subsequent Screening Mammography
- Author
-
Taplin, Stephen H., primary, Abraham, L., additional, Geller, B. M., additional, Yankaskas, B. C., additional, Buist, D. S. M., additional, Smith-Bindman, R., additional, Lehman, C., additional, Weaver, D., additional, Carney, P. A., additional, and Barlow, W. E., additional
- Published
- 2010
- Full Text
- View/download PDF
3. Variability of Interpretive Accuracy Among Diagnostic Mammography Facilities
- Author
-
Jackson, Sara L., primary, Taplin, Stephen H., additional, Sickles, Edward A., additional, Abraham, Linn, additional, Barlow, William E., additional, Carney, Patricia A., additional, Geller, Berta, additional, Berns, Eric A., additional, Cutter, Gary R., additional, and Elmore, Joann G., additional
- Published
- 2009
- Full Text
- View/download PDF
4. Explaining Black–White Differences in Receipt of Recommended Colon Cancer Treatment
- Author
-
Baldwin, Laura-Mae, primary, Dobie, Sharon A., additional, Billingsley, Kevin, additional, Cai, Yong, additional, Wright, George E., additional, Dominitz, Jason A., additional, Barlow, William, additional, Warren, Joan L., additional, and Taplin, Stephen H., additional
- Published
- 2005
- Full Text
- View/download PDF
5. Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process
- Author
-
Leyden, Wendy A., primary, Manos, M. Michele, additional, Geiger, Ann M., additional, Weinmann, Sheila, additional, Mouchawar, Judy, additional, Bischoff, Kimberly, additional, Yood, Marianne Ulcickas, additional, Gilbert, Joyce, additional, and Taplin, Stephen H., additional
- Published
- 2005
- Full Text
- View/download PDF
6. Testing Reminder and Motivational Telephone Calls to Increase Screening Mammography: a Randomized Study
- Author
-
Taplin, Stephen H., primary, Barlow, William E., additional, Ludman, Evette, additional, MacLehos, Richard, additional, Meyer, Dolores M., additional, Seger, Deborah, additional, Herta, Douglas, additional, Chin, Craig, additional, and Curry, Susan, additional
- Published
- 2000
- Full Text
- View/download PDF
7. Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care
- Author
-
Taplin, Stephen H., primary, Barlow, William, additional, Urban, Nicole, additional, Mandelson, Margaret T., additional, Timlin, Deborah J., additional, Ichikawa, Laura, additional, and Nefcy, Pauline, additional
- Published
- 1995
- Full Text
- View/download PDF
8. Effectiveness of computer-aided detection in community mammography practice.
- Author
-
Fenton JJ, Abraham L, Taplin SH, Geller BM, Carney PA, D'Orsi C, Elmore JG, Barlow WE, Breast Cancer Surveillance Consortium, Fenton, Joshua J, Abraham, Linn, Taplin, Stephen H, Geller, Berta M, Carney, Patricia A, D'Orsi, Carl, Elmore, Joann G, and Barlow, William E
- Abstract
Background: Computer-aided detection (CAD) is applied during screening mammography for millions of US women annually, although it is uncertain whether CAD improves breast cancer detection when used by community radiologists.Methods: We investigated the association between CAD use during film-screen screening mammography and specificity, sensitivity, positive predictive value, cancer detection rates, and prognostic characteristics of breast cancers (stage, size, and node involvement). Records from 684 956 women who received more than 1.6 million film-screen mammograms at Breast Cancer Surveillance Consortium facilities in seven states in the United States from 1998 to 2006 were analyzed. We used random-effects logistic regression to estimate associations between CAD and specificity (true-negative examinations among women without breast cancer), sensitivity (true-positive examinations among women with breast cancer diagnosed within 1 year of mammography), and positive predictive value (breast cancer diagnosed after positive mammograms) while adjusting for mammography registry, patient age, time since previous mammography, breast density, use of hormone replacement therapy, and year of examination (1998-2002 vs 2003-2006). All statistical tests were two-sided.Results: Of 90 total facilities, 25 (27.8%) adopted CAD and used it for an average of 27.5 study months. In adjusted analyses, CAD use was associated with statistically significantly lower specificity (OR = 0.87, 95% confidence interval [CI] = 0.85 to 0.89, P < .001) and positive predictive value (OR = 0.89, 95% CI = 0.80 to 0.99, P = .03). A non-statistically significant increase in overall sensitivity with CAD (OR = 1.06, 95% CI = 0.84 to 1.33, P = .62) was attributed to increased sensitivity for ductal carcinoma in situ (OR = 1.55, 95% CI = 0.83 to 2.91; P = .17), although sensitivity for invasive cancer was similar with or without CAD (OR = 0.96, 95% CI = 0.75 to 1.24; P = .77). CAD was not associated with higher breast cancer detection rates or more favorable stage, size, or lymph node status of invasive breast cancer.Conclusion: CAD use during film-screen screening mammography in the United States is associated with decreased specificity but not with improvement in the detection rate or prognostic characteristics of invasive breast cancer. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
9. Biennial Versus Annual Mammography and the Risk of Late-Stage Breast Cancer.
- Author
-
White, Emily, Miglioretti, Diana L., Yankaskas, Bonnie C., Geller, Berta M., Rosenberg, Robert D., Kerlikowske, Karla, Saba, Laura, Vacek, Pamela M., Carney, Patricia A., Buist, Diana S. M., Oestreicher, Nina, Barlow, William, Ballard-Barbash, Rachel, and Taplin, Stephen H.
- Subjects
MAMMOGRAMS ,BREAST exams ,CANCER diagnosis ,BREAST cancer ,MORTALITY ,CANCER in women ,AMERICAN women - Abstract
Background: Mammography screening may reduce breast cancer mortality by detecting cancers at an earlier stage. However, certain questions remain, including the ideal interval between mammograms. Methods: We conducted an observational study using information collected by seven mammography registries across the United States to investigate whether women diagnosed with breast cancer after having screening mammograms separated by a 2-year interval (n = 2440) are more likely to be diagnosed with late-stage disease (positive lymph nodes or metastases) than women diagnosed with breast cancer after having screening mammograms separated by a 1-year interval (n = 5400). Analyses were stratified by age and breast density to clarify whether groups that have the poorest mammography sensitivity (i.e., women under age 50 years and those with mammographically dense breasts) would benefit most from annual screening. The subjects were women diagnosed with breast cancer between 1996 and 2001 who were 40–89 years old at their index mammographic examination (i.e., the most recent screen at or before breast cancer diagnosis). Data were analyzed by logistic regression, adjusting for race, ethnicity, family history of breast cancer, and mammography registry. Results: Among women age 40–49 years at the index mammogram, those with a 2-year screening interval were more likely to have late-stage disease at diagnosis than those with a 1-year screening interval (28% versus 21%; odds ratio [OR] = 1.35, 95% confidence interval [CI] = 1.01 to 1.81). There was no increase in late-stage disease for women 50 years or older with a 2-year versus a 1-year screening interval (women age 50–59 years at index mammogram: OR = 0.97, 95% CI = 0.75 to 1.25; women age 60–69 years at index mammogram: OR = 0.99, 95% CI = 0.72 to 1.35; women age 70 years or older at index mammogram: OR = 0.88, 95% CI = 0.64 to 1.19). There was no indication that women with dense breasts would benefit more from a 1-year versus 2-year screening interval than women with fatty breasts. Conclusion: These findings may be useful for policy decisions about appropriate screening intervals and for use in statistical models that estimate the costs and benefits of mammography by age and screening interval. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
10. Accuracy of Screening Mammography Interpretation by Characteristics of Radiologists.
- Author
-
Barlow, William E., Chen Chi, Carney, Patricia A., Taplin, Stephen H., D'Orsi, Carl, Cutter, Gary, Hendrick, R. Edward, and Elmore, Joann G.
- Subjects
MEDICAL screening ,MAMMOGRAMS ,RADIOLOGISTS ,BREAST cancer ,CANCER diagnosis ,BREAST exams ,CANCER in women - Abstract
Background: Radiologists differ in their ability to interpret screening mammograms accurately. We investigated the relationship of radiologist characteristics to actual performance from 1996 to 2001. Methods: Screening mammograms (n = 469 512) interpreted by 124 radiologists were linked to cancer outcome data. The radiologists completed a survey that included questions on demographics, malpractice concerns, years of experience interpreting mammograms, and the number of mammograms read annually. We used receiver operating characteristics (ROC) analysis to analyze variables associated with sensitivity, specificity, and the combination of the two, adjusting for patient variables that affect performance. All P values are two-sided. Results: Within 1 year of the mammogram, 2402 breast cancers were identified. Relative to low annual interpretive volume (≤1000 mammograms), greater interpretive volume was associated with higher sensitivity (P = .001; odds ratio [OR] for moderate volume [1001-2000] = 1.68, 95% CI = 1.18 to 2.39; OR for high volume [>2000] = 1.89, 95% CI = 1.36 to 2.63). Specificity decreased with volume (OR for 1001-2000 = 0.65, 95% CI = 0.52 to 0.83; OR for more than 2000 = 0.76, 95% CI = 0.60 to 0.96), compared with 1000 or less (P = .002). Greater number of years of experience interpreting mammograms was associated with lower sensitivity (P = .001), but higher specificity (P = .003). ROC analysis using the ordinal BI-RADS interpretation showed an association between accuracy and both previous mammographic history (P = .012) and breast density (P<.001). No association was observed between accuracy and years interpreting mammograms (P = .34) or mammography volume (P = .94), alter adjusting for variables that affect the threshold for calling a mammogram positive. Conclusions: We found no evidence that greater volume or experience at interpreting mammograms is associated with better performance. However, they may affect sensitivity and specificity, possibly by determining the threshold for calling a mammogram positive. Increasing volume requirements is unlikely to improve overall mammography performance. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
11. Reason for Late-Stage Breast Cancer: Absence of Screening or Detection, or Breakdown in Follow-up?
- Author
-
Taplin, Stephen H., Ichikawa, Laura, Yood, Marianne Ulcickas, Michele Manos, M., Geiger, Ann M., Weinmann, Sheila, Gilbert, Joyce, Mouchawar, Judy, Leyden, Wendy A., Altaras, Robin, Beverly, Robert K., Casso, Deborah, Westbrook, Emily Oakes, Bischoff, Kimberly, Zapka, Jane G., and Barlow, William E.
- Subjects
- *
HEALTH planning , *BREAST cancer , *CANCER in women , *MAMMOGRAMS , *BREAST exams , *WOMEN'S health - Abstract
Background: Mammography screening increases the detection of early-stage breast cancers. Therefore, implementing screening should reduce the percentage of women who are diagnosed with late-stage disease. However, despite high national mammography screening rates, late-stage breast cancers still occur, possibly because of failures in screening implementation. Methods: Using data from seven health care plans that included 1.5 million women aged 50 years or older, we conducted retrospective reviews of chart and automated data for 3 years before 1995–1999 diagnoses of late-stage (metastatic and/or tumor size ≥3 cm; case subjects, n = 1347) and early-stage breast cancers (control subjects, n = 1347). We categorized the earliest screening mammogram during the period 13–36 months before diagnosis as none (absence of screening), negative (absence of detection), or positive (potential breakdown in follow-up). We compared the proportion of case and control subjects in each category of screening implementation and estimated the likelihood (odds ratio [OR] with 95% confidence intervals [CIs]) of late-stage breast cancer. We also evaluated demographic characteristics associated with absence of screening in women with late-stage disease. All statistical tests were two-sided. Results: Absence of screening, absence of detection, and potential breakdown in follow-up were distributed differently among case (52.1%, 39.5%, and 8.4%, respectively) and control subjects (34.4%, 56.9%, and 8.8%, respectively) (P = .03). Among all women, the odds of having late-stage cancer were higher among women with an absence of screening (OR = 2.17, 95% CI = 1.84 to 2.56; P<.001). Among case patients, women were more likely to be in the absence-of-screening group if they were aged 75 years or older (OR = 2.77, 95% CI = 2.10 to 3.65), unmarried (OR = 1.78, 95% CI = 1.41 to 2.24), or without a family history of breast cancer (OR = 1.84, 95% CI = 1.45 to 2.34). A higher proportion of women from census blocks with less education (58.5% versus 49.4%; P = .003) or lower median annual income (54.4% versus 42.9%; P = .004) were in the absence-of-screening category compared with the proportion for the other two categories combined. Conclusions: To reduce late-stage breast cancer occurrence, reaching unscreened women, including elderly, unmarried, low-income, and less educated women, should be made a top priority for screening implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
12. Factors contributing to mammography failure in women aged 40-49 years.
- Author
-
Buist DSM, Porter PL, Lehman C, Taplin SH, White E, Buist, Diana S M, Porter, Peggy L, Lehman, Constance, Taplin, Stephen H, and White, Emily
- Abstract
Background: Younger women (40-49 years) have lower mammographic sensitivity (i.e., greater proportion of cancers detected after a negative mammogram) than older women (> or =50 years). We explored the effect of tumor growth rate, breast density, mammographic image quality, and breast cancer risk factors on mammographic sensitivity in younger and older women.Methods: We studied 576 women (n = 73 aged 40-49 years and n = 503 aged 50 years or older) who were diagnosed with invasive breast cancer between 1988 and 1993. Interval cancers were defined as those diagnosed within 12 or 24 months after a negative screening mammogram and before a subsequent mammogram. Tumor growth rate was assessed by mitotic figure count and Ki-67 positivity. The main outcome measures were percentage of women with interval cancer (1 -mammographic sensitivity) by age, odds ratio (OR) of interval cancer by age, and excess odds (i.e., the percentage of the odds ratio for age that was explained by individual covariates).Results: Interval cancers occurred in 27.7% of younger women and 13.9% of older women within 12 months (OR = 2.36, 95% confidence interval [CI] = 1.14 to 4.77) and in 52.1% of younger women and 24.7% of older women within 24 months (OR = 3.58, 95% CI = 2.15 to 5.97). Greater breast density explained 67.6% of the decreased mammographic sensitivity in younger women at 12 months, whereas rapid tumor growth explained 30.6% and breast density explained 37.6% of the decreased sensitivity in younger women at 24 months.Conclusions: Breast density largely explained decreased mammographic sensitivity at 12 months, whereas rapid tumor growth contributed to decreased mammographic sensitivity at 24 months. A 12-month versus a 24-month mammography screening interval may therefore reduce the adverse impact of faster growing tumors on mammographic sensitivity in younger women. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
13. Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography.
- Author
-
Ernster, Virginia L., Ballard-Barbash, Rachel, Barlow, William E., Yingye Zheng, Weaver, Donald L., Cutter, Gary, Yankaskas, Bonnie C., Rosenberg, Robert, Carney, Patricia A., Kerlikowske, Karla, Taplin, Stephen H., Urban, Nicole, and Geller, Berta M.
- Subjects
MAMMOGRAMS ,CANCER - Abstract
Examines the detection of ductal carcinoma in situ (DCIS) in women undergoing screening mammography in the U.S. Total number of identified cases of breast cancer; Decrease in the percentage of screen-detected DCIS breast cancers; Increase in the incidence rates of DCIS of the breast.
- Published
- 2002
- Full Text
- View/download PDF
14. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
- Author
-
Barlow, William E., Taplin, Stephen H., Yoshida, Cathleen K., Buist, Diana S., Seger, Deborah, Brown, Martin, Barlow, W E, Taplin, S H, Yoshida, C K, Buist, D S, Seger, D, and Brown, M
- Subjects
- *
BREAST cancer treatment , *MEDICAL care costs , *WOMEN'S health services , *COST - Abstract
Background: Choice of treatment for early-stage breast cancer depends on many factors, including the size and stage of the cancer, the woman's age, comorbid conditions, and perhaps the costs of treatment. We compared the costs of all medical care for women with early-stage breast cancer cases treated by breast-conserving therapy (BCT) or mastectomy.Methods: A total of 1675 women 35 years old or older with incident early-stage breast cancer were identified in a large regional nonprofit health maintenance organization in the period 1990 through 1997. The women were treated with mastectomy only (n = 183), mastectomy with adjuvant hormonal therapy or chemotherapy (n = 417), BCT with radiation therapy (n = 405), or BCT with radiation therapy and adjuvant hormonal therapy or chemotherapy (n = 670). The costs of all medical care for the period 1990 through 1998 were computed for each woman, and monthly costs were analyzed by treatment, adjusting for age and cancer stage. All statistical tests were two-sided.Results: At 6 months after diagnosis, the mean total medical care costs for the four groups differed statistically significantly (P:<.001), with BCT being more expensive than mastectomy. The adjusted mean costs were $12 987, $14 309, $14 963, and $15 779 for mastectomy alone, mastectomy with adjuvant therapy, BCT plus radiation therapy, and BCT plus radiation therapy with adjuvant therapy, respectively. At 1 year, the difference in costs was still statistically significant (P:<.001), but costs were influenced more by the use of adjuvant therapy than by type of surgery. The 1-year adjusted mean costs were $16 704, $18 856, $17 344, and $19 081, respectively, for the four groups. By 5 years, BCT was less expensive than mastectomy (P:<.001), with 5-year adjusted mean costs of $41 930, $45 670, $35 787, and $39 926, respectively. Costs also varied by age, with women under 65 years having higher treatment costs than older women.Conclusions: BCT may have higher short-term costs but lower long-term costs than mastectomy. [ABSTRACT FROM AUTHOR]- Published
- 2001
- Full Text
- View/download PDF
15. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years.
- Author
-
White, Emily, Velentgas, Priscilla, Mandelson, Margaret T., Lehman, Constance D., Elmore, Joann G., Porter, Peggy, Yasui, Yutaka, Taplin, Stephen H., White, E, Velentgas, P, Mandelson, M T, Lehman, C D, Elmore, J G, Porter, P, Yasui, Y, and Taplin, S H
- Subjects
MENSTRUATION ,MAMMOGRAMS ,WOMEN - Abstract
Background: Mammography is less effective for women aged 40-49 years than for older women, which has led to a call for research to improve the performance of screening mammography for younger women. One factor that may influence the performance of mammography is breast density. Younger women have greater mammographic breast density on average, and increased breast density increases the likelihood of false-negative and false-positive mammograms. We investigated whether breast density varies according to time in a woman's menstrual cycle.Methods: Premenopausal women aged 40-49 years who were not on exogenous hormones and who had a screening mammogram at a large health maintenance organization during 1996 were studied (n = 2591). Time in the menstrual cycle was based on the woman's self-reported last menstrual bleeding and usual cycle length.Results: A smaller proportion of women had "extremely dense" breasts during the follicular phase of their menstrual cycle (24% for week 1 and 23% for week 2) than during the luteal phase (28% for both weeks 3 and 4) (two-sided P = .04 for the difference in breast density between the phases, adjusted for body mass index). The relationship was stronger for women whose body mass index was less than or equal to the median (two-sided P<.01), the group who have the greatest breast density.Conclusions/implications: These findings are consistent with previous evidence suggesting that scheduling a woman's mammogram during the follicular phase (first and second week) of her menstrual cycle instead of during the luteal phase (third and fourth week) may improve the accuracy of mammography for premenopausal women in their forties. Breast tissue is less radiographically dense in the follicular phase than in the luteal phase. [ABSTRACT FROM AUTHOR]- Published
- 1998
- Full Text
- View/download PDF
16. Re: Breast cancer screening comes full circle.
- Author
-
Taplin, Stephen H., Barlow, William E., Ulcickas-Yood, Marianne, Westbrook, Emily Oakes, Geiger, Ann M., Bischoff, Kimberly, Ichikawa, Laura, Westbrook, Emily, and Bischoff, Kimberley
- Subjects
- *
LETTERS to the editor , *BREAST cancer diagnosis , *MEDICAL screening - Abstract
Presents a letter to the editor concerning breast cancer screening.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.